A PLACEBO-CONTROLLED PHASE 1 STUDY IN HEALTHY ADULT VOLUNTEERS OF THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF POVETACICEPT, A POTENT DUAL BAFF/APRIL ANTAGONIST, FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS

Authors
Category Primary study
JournalLupus Science and Medicine
Year 2023
This article has no abstract
Epistemonikos ID: 94b115955a23ac726132a1f63f6da08296672441
First added on: Dec 07, 2023